Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study

Fig. 1

Treatment response rate in patients with locally advanced ESCC. Treatment response rate concerning CR, PR, SD, and PD (a). Treatment response rate concerning ORR and DCR (b) adopting neoadjuvant camrelizumab plus chemotherapy in locally advanced ESCC. CR, complete remission; PR, partly remission; SD, stable disease; PD, progressive disease; ORR, objective remission rate; DCR, disease control rate; ESCC, esophageal squamous cell carcinoma

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us